Weijing Ye
Papers
1
Total Citations
5
H-Index
1
About
Weijing Ye is a rising innovator in drug delivery and biomedical engineering, with a focused expertise in microneedle technology for overcoming biological barriers. Her work centers on advancing biomacromolecular delivery—enabling the therapeutic application of proteins, peptides, and nucleic acids in major diseases including tumors, infections, cardiovascular conditions, metabolic disorders, and autoimmune diseases. Ye’s most-cited paper, “Microneedle Technology for Overcoming Biological Barriers” (2025), has already garnered 5 citations, signaling early impact in a rapidly evolving field. She addresses a critical bottleneck: while biomacromolecules offer transformative therapeutic potential, their administration remains heavily dependent on professional healthcare settings. By engineering microneedle platforms that bypass traditional barriers, Ye’s research paves the way for patient-friendly, self-administered treatments. Her contributions are particularly notable for bridging materials science and clinical translation, offering practical solutions for diseases that affect millions worldwide. As her citation record grows, Weijing Ye is establishing herself as a key voice in next-generation drug delivery systems.
Research Focus
Key Achievements
Top Papers
- 1